FluMist is the first vaccine to prevent influenza that does not need to be administered by a healthcare provider, the ...
First Influenza Vaccine That Does Not Need to be Administered by a Health Care Provider ...
The Food and Drug Administration announced on Friday an approval of a new self- and caregiver-administered nose spray against ...
The U.S. FDA has given the green light for AstraZeneca's FluMist nasal spray vaccine to be self-administered or administered ...
On Friday, the US Food and Drug Administration approved UK pharma major AstraZeneca’s (LSE: AZN) FluMist for self- or ...
FluMist, a needle-free nasal spray influenza vaccine, has been approved by the FDA for self-administration in the US, making ...
Today’s approval means that FluMist is the first pharmacy-prescribed influenza vaccine that does not need to be given by a ...
AstraZeneca has just scored big on the quest to make routine vaccinations less of a hassle. | The FDA signed off on ...
Through a third-party pharmacy, people interested in the self or caregiver option will complete a screening and eligibility ...
AstraZeneca has announced that FluMist has been approved in the US as the self-administered influenza vaccine. FluMist, a ...
WILMINGTON, Del.--(BUSINESS WIRE)--FLUMIST ® has been approved in the US as the only self-administered influenza vaccine. FLUMIST, a needle-free nasal spray, was approved to be self-administered by ...
FluMist is a nasally-administered influenza vaccine that is indicated for active immunization to prevent influenza disease in individuals 2 to 49 years of age.